SUMMARY Twenty-four patients with rheumatoid arthritis and isolated haematuria were investigated for the cause of their haematuria. In 3 patients local urological disorders were identified, including a pelvicaliceal carcinoma. Renal biopsies were performed on the remaining 21 patients, and the most common abnormality found was a mild mesangial glomerulonephritis (71%). Immunofluorescence and electron microscopy in these patients usually gave normal results. The lesions occurred independently of gold or D-penicillamine therapy and were not associated with impairment of glomerular function.
Renal involvement in rheumatoid arthritis is well recognised but is usually attributed to either the development of amyloidosis, adverse reactions to gold or penicillamine, analgesic nephropathy, or an interstitial nephritis with tubular dysfunction in patients with associated keratoconjunctivitis sicca. The presence of a specific renal lesion occurring in rheumatoid arthritis remains controversial.' Postmortem studies have suggested the presence of both renal vasculitis and mild mesangial glomerulonephritis,2 and the latter finding has also been reported in a group of patients receiving gold therapy.3 This study is based on the clinicopathological findings in a group of 31 patients suffering from rheumatoid arthritis who were found to have recurrent, asymptomatic, microscopical haematuria occurring in the absence of urinary infection. Only a minority of these patients had had or were receiving either gold or penicillamine therapy, and the most common abnormality detected was that of a mild mesangial glomerulonephritis.
Patients and methods
Patients were included in the study on Light microscopy. The findings on renal biopsy are shown in Table 2 . The most common abnormality was a mild, mesangial glomerulonephritis present in 15 patients (71%) (Fig. 1) . None of these patients had an increased serum creatinine. Two of the patients were receiving D-penicillamine; one had had 100 to 200 mg daily for 12 months, the other 125 to 250 mg daily for 5 months. A third case had received a total dose of 30 mg of Myocrisin. All were receiving nonsteroidal anti-inflammatory drugs, and one patient was receiving hydroxychloroquine. The patient who showed a membranous glomerulonephritis on renal biopsy did not have proteinuria. At the time of biopsy the patient was receiving penicillamine 50 mg daily for 4 weeks but had previously received a course of Myocrisin (total 1150 mg), which had been discontinued 6 months before biopsy because of thrombocytopenia.
The patient with interstitial fibrosis had keratoconjunctivitis sicca and nodular rheumatoid arthritis. There was no history of analgesic abuse.
One patient developed persistent haematuria after 3 doses (225 mg total) of penicillamine. She had a normal renal biopsy and cystoscopic appearances were normal; the cause of her haematuria was not apparent.
Serum creatinine levels were elevated in only 2 patients. One male patient had a focal glomerulonephritis with crescents (Fig. 2) glomerulonephritis. Electron dense deposits were seen in only one of these 7 patients and were present on the subendothelial basement membrane.
Immunofluorescence. Immunofluorescence for IgG, A, M, C3, and fibrin was tested in 10 of the 14 patients with mesangial glomerulonephritis. No significant immunofluorescence could be detected in 7. Of the remainder 2 had granular deposits in the mesangium; these were IgM in one and IgG, A, M, and C3 in the other. The final patient had tubular casts containing IgA and fibrin.
Discussion
The finding that one of our patients had a surgically treatable renal pelvicaliceal carcinoma obviously stresses the need for complete evaluation of any patient with haematuria. However, the most common abnormality detected in the present series was in renal histology, in particular, a mild mesangial glomerulonephritis. Such changes have recently been reported in a post-mortem series of 76 rheumatoid patients, where mesangial proliferation was found in 38% of the patients compared with 15% of the controls.2 Similar histological abnormalities have also been detected in renal biopsy specimens from patients who developed proteinuria or haematuria while receiving gold,3 and the renal abnormalities were attributed to Myocrisin therapy. Such an explanation would seem unlikely on the basis of our findings, as only 3 of the 14 patients with mesangial glomerulonephritis were receiving either gold or penicillamine therapy. Whether the mesangial changes are casually or causally related to the haematuria is difficult to establish from the present series, as it was considered unethical to take biopsy specimens from patients with rheumatoid arthritis who did not have urinary abnormalities. It would seem probable, however, that the renal changes are related to the haematuria, as similar findings on renal biopsy have also been reported in nonrheumatoid patients with asymptomatic haematuria. ' Previous series describing the findings on renal biopsy from unselected rheumatoid patients have usually failed to detect any evidence of mesangial proliferation,"8 though a localised 'glomerulitis' was detected in over half of the 20 patients studied by Pastemack et al. 9 On balance, however, ptesent evidence suggests that a mesangial glomerulonephritis is not a common finding on renal biopsy in unselected rheumatoid patients, and further supports the view that the changes observed in our series probably are related to the persistent haematuria.
The aetiology of the mesangial glomerulonephritis is uncertain. While this may be on the basis of circulating immune complexes, the relative infrequency of both immunoglobulin deposition and electron dense deposits is in marked contrast with the findings in systemic lupus erythematosus.'0 It is possible that we have merely observed a fortuitous association of haematuria, which may be present in 1% of the population,11 and rheumatoid arthritis. However, this seems unlikely, as we did not encounter any cases of haematuria in patients who had osteoarthritis. It The absence of amyloidosis in these patients is undoubtedly due to the fact that patients with proteinuria were excluded, but it is of interest that no cases of analgesic nephropathy were encountered. This probably reflects both the removal of phenacetin from analgesic preparations and the more cautious use of analgesics in rheumatoid patients. We also failed to detect any cases of renal vasculitis, a condition which has previously been reported in post-mortem studies."3 This may reflect the sampling size of percutaneous renal biopsy specimens, but other series reporting on renal biopsies in rheumatoid patients have also failed to detect histological evidence of renal vasculitis."9
It would seem therefore that, while surgical causes of haematuria have to be sought in patients with rheumatoid arthritis, the most common abnormality is found on renal biopsy-in particular, a mild, mesangial glomerulonephritis. This does not appear to have an adverse effect on renal function or to be associated with second-line therapy. 
